A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy (Q44129220)
Jump to navigation
Jump to search
scientific article published in September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy |
scientific article published in September 2002 |
Statements
1 reference
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy (English)
1 reference
Ursula Matulonis
1 reference
Michael V Seiden
1 reference
Kenneth D Swenerton
1 reference
Susan Campos
1 reference
Peter Rose
1 reference
Gerald Batist
1 reference
Ene Ette
1 reference
Varun Garg
1 reference
Arlan Fuller
1 reference
Matthew W Harding
1 reference
Danielle Charpentier
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference